BAUSCH HEALTH AMERICAS, INC.
Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face
- Conditions
- Interventions
- First Posted Date
- 2009-06-12
- Last Posted Date
- 2012-02-15
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00919191
- Locations
- 🇺🇸
Skin Study Center, Broomall, Pennsylvania, United States
A Study of Acne Treatment in Children Ages 9 to 11
- Conditions
- Interventions
- First Posted Date
- 2009-05-22
- Last Posted Date
- 2012-02-15
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT00907335
- Locations
- 🇺🇸
Dermatology Research Associates, Cincinnatti, Ohio, United States
🇺🇸Department of Dermatology, Northwestern University, Chicago, Illinois, United States
🇺🇸Encino Research Center, Encino, California, United States
A Study of Different Use Regimens Using Two Acne Treatments
- First Posted Date
- 2009-05-22
- Last Posted Date
- 2012-02-15
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 247
- Registration Number
- NCT00907257
- Locations
- 🇺🇸
International Dermatology Research, Inc., Miami, Florida, United States
🇺🇸DermResearch Center of New York, Stony Brook, New York, United States
🇺🇸Derm Research, PLLC, Louisville, Kentucky, United States
Biopsy Study for Sculptra (Poly-L-Lactic Acid)
- Conditions
- Interventions
- First Posted Date
- 2009-03-26
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT00869687
- Locations
- 🇨🇦
Sanofi-Aventis Administrative Office, Laval, Canada
Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827
- Conditions
- Interventions
- First Posted Date
- 2009-03-23
- Last Posted Date
- 2019-01-16
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT00867100
Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects
- Conditions
- Interventions
- First Posted Date
- 2009-03-10
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- Bausch Health Americas, Inc.
- Registration Number
- NCT00858754
- Locations
Pfizer Investigational Site
Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation
- First Posted Date
- 2008-12-08
- Last Posted Date
- 2019-10-18
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 1040
- Registration Number
- NCT00804141
- Locations
- 🇪🇸
Pfizer Investigational Site, Madrid, Madrid/Spain, Spain
(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
- Conditions
- Interventions
- First Posted Date
- 2008-12-03
- Last Posted Date
- 2020-08-31
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT00801723
- Locations
- 🇺🇸
Santarus Clinical Investigational Site 5077, Prince Frederick, Maryland, United States
🇺🇸Santarus Clinical Investigational Site 5067, San Diego, California, United States
🇺🇸Santarus Clinical Investigational Site 5044, Anaheim, California, United States
Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring
- Conditions
- Interventions
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT00795327
- Locations
- 🇨🇦
Sanofi-Aventis Administrative Office, Laval, Canada
Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 256
- Registration Number
- NCT00767728